IL326142A - הרכב חדשני לניסוח תרחיף - Google Patents

הרכב חדשני לניסוח תרחיף

Info

Publication number
IL326142A
IL326142A IL326142A IL32614226A IL326142A IL 326142 A IL326142 A IL 326142A IL 326142 A IL326142 A IL 326142A IL 32614226 A IL32614226 A IL 32614226A IL 326142 A IL326142 A IL 326142A
Authority
IL
Israel
Prior art keywords
novel composition
suspension formulation
formulation
suspension
novel
Prior art date
Application number
IL326142A
Other languages
English (en)
Inventor
Ramesh S
Bindumadavan K
Sampathkumar Devarajan
Jitesh Devendra
Original Assignee
Axxelent Pharma Science Private Ltd
Ramesh S
Bindumadavan K
Sampathkumar Devarajan
Jitesh Devendra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axxelent Pharma Science Private Ltd, Ramesh S, Bindumadavan K, Sampathkumar Devarajan, Jitesh Devendra filed Critical Axxelent Pharma Science Private Ltd
Publication of IL326142A publication Critical patent/IL326142A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
IL326142A 2023-07-27 2024-07-27 הרכב חדשני לניסוח תרחיף IL326142A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202341035766 2023-07-27
PCT/IN2024/051397 WO2025022463A1 (en) 2023-07-27 2024-07-27 Novel composition for suspension formulation

Publications (1)

Publication Number Publication Date
IL326142A true IL326142A (he) 2026-03-01

Family

ID=94374307

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326142A IL326142A (he) 2023-07-27 2024-07-27 הרכב חדשני לניסוח תרחיף

Country Status (6)

Country Link
KR (1) KR20260043106A (he)
CN (1) CN121866060A (he)
AU (1) AU2024301186A1 (he)
CO (1) CO2026000821A2 (he)
IL (1) IL326142A (he)
WO (1) WO2025022463A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR125970A1 (es) * 2021-05-28 2023-08-30 Sk Biopharmaceuticals Co Ltd Formulaciones de suspensión acuosa para administración oral que comprenden un compuesto de carbamato

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4243796A4 (en) * 2020-11-16 2025-01-22 Orcosa Inc. IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
AR125970A1 (es) * 2021-05-28 2023-08-30 Sk Biopharmaceuticals Co Ltd Formulaciones de suspensión acuosa para administración oral que comprenden un compuesto de carbamato

Also Published As

Publication number Publication date
KR20260043106A (ko) 2026-03-31
WO2025022463A1 (en) 2025-01-30
CN121866060A (zh) 2026-04-14
AU2024301186A1 (en) 2026-02-05
CO2026000821A2 (es) 2026-02-13

Similar Documents

Publication Publication Date Title
GB202319994D0 (en) Compositions for use
GB202207345D0 (en) Novel composition
GB202204326D0 (en) Composition
EP4516815A4 (en) COMPOSITION
GB202207344D0 (en) Novel composition
EP4489582A4 (en) MEAT ANALOGUE COMPOSITION
GB202209574D0 (en) Composition
GB2607554B (en) Novel composition
GB202102258D0 (en) Novel composition
GB202315850D0 (en) Novel composition
GB202315843D0 (en) Novel composition
GB202315847D0 (en) Novel composition
GB202306585D0 (en) Novel composition
GB202219376D0 (en) Novel composition
GB202216461D0 (en) Novel composition
GB202209540D0 (en) Novel composition
GB202202970D0 (en) Composition for use
GB202316194D0 (en) Novel compositions
GB202217025D0 (en) Novel compositions
EP4559537A4 (en) COMPOSITION
EP4509562A4 (en) COMPOSITION
GB202216888D0 (en) Composition
GB202216893D0 (en) Composition
GB202215134D0 (en) Composition
GB202214997D0 (en) Composition